SUPERGEN INC
10-Q, EX-27.1, 2000-11-13
PHARMACEUTICAL PREPARATIONS
Previous: SUPERGEN INC, 10-Q, 2000-11-13
Next: NORTHWEST INDIANA BANCORP, 10-Q, 2000-11-13



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM SUPERGEN.
INC SEPTEMBER 30,2000 CONSOLIDATED FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          86,190
<SECURITIES>                                    20,300
<RECEIVABLES>                                      552
<ALLOWANCES>                                        10
<INVENTORY>                                      1,435
<CURRENT-ASSETS>                               112,111
<PP&E>                                           5,240
<DEPRECIATION>                                   1,844
<TOTAL-ASSETS>                                 176,126
<CURRENT-LIABILITIES>                            5,701
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       287,187
<OTHER-SE>                                     (1,961)
<TOTAL-LIABILITY-AND-EQUITY>                   176,126
<SALES>                                          4,006
<TOTAL-REVENUES>                                 4,743
<CGS>                                              938
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                35,114
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                               (25,340)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (25,340)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (25,340)
<EPS-BASIC>                                     (0.81)
<EPS-DILUTED>                                   (0.81)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission